Group structure
6 companies in 5 countries
Loading…
6 companies in 5 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
8 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACIDO FÓLICO ASPOL 10MG CÁPSULAS DURAS10 mg · Cápsula dura | Folic acid | Spain | Marketed | 1974 |
| INTERCOLD GRANULADO PARA SOLUCION ORAL1.000 mg + 15,58 mg + 4 mg · Granulado para solución oral | Paracetamol, Fenilefrina bitartrato, Chlorpheniramine | Spain | Marketed | 2022 |
| INTERDERM CREMA 30 GRAMOS1 mg + 100 kilo UI + 1 mg · Crema | Gentamicin, Nystatin, Triamcinolone | Spain | Marketed | 1974 |
| INTERFRIN 0,5 mg/ml SOLUCION PARA PULVERIZACION NASAL0,5 mg · Solucion para pulverizacion nasal | Oxymetazoline | Spain | Marketed | 2002 |
| INTERGRIP POLVO PARA SOLUCION ORAL650 mg + 25 mg + 4 mg · Polvo para solución oral | Paracetamol, Caffeine, Chlorpheniramine | Spain | Marketed | 2007 |
| INTERMUCOL 750 mg SOLUCION ORAL750 mg · Solución oral | Carbocisteine | Spain | Marketed | 2008 |
| INTERTOS 15 MG COMPRIMIDOS15 mg · Comprimido | Dextromethorphan | Spain | Marketed | 2018 |
| ORALTAG9.7gm/bot · For solution | Iohexol | United States | Not marketed | 2015 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 7 | 7 | 0 | CompaniesAll medicines |
| United States | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Australia, Canada, Colombia, Croatia
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Licence: Creative Commons Attribution 3.0 Australia
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Report an error or request removalCorrections from the company itself are welcome.
Keep Interpharma’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.